Privia Health Group, Inc.
PRVA Healthcare Health Information Services
Privia Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, up 22.3% from fiscal 2024.
- Revenue
- +13.2%
- EPS
- +83.3%
- Free cash flow
- −44.4%
Quarter to September 2026, against a year earlier
Follow PRVA
Alert me
Privia Health Group, Inc. (PRVA) P/E ratio
As of 5 November 2026, Privia Health Group, Inc. (PRVA) trades at a P/E ratio of 88.3×. Over the past ten years it has ranged from 0.0× (March 2023) to 230× (May 2023); the current reading is higher than 41% of that period. That is above the Health Information Services industry median of 42.0× and above the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 132× | (12.41%) |
| FY2024 | 150× | 20.51% |
| FY2023 | 125× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 70.4× | 0.00% |
| FY2019 | 70.4× | 0.00% |
| FY2018 | 70.4× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 72.9× | (37.65%) |
| Jun 2026 | 117× | (3.34%) |
| Mar 2026 | 121× | (8.14%) |
| Dec 2025 | 132× | (20.65%) |
| 23 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| CERT Certara, Inc. compare | n/m |
| HTFL Heartflow, Inc. compare | n/m |
| SDGR Schrodinger, Inc. compare | n/m |
| TDOC Teladoc Health, Inc. compare | n/m |
| OMCL Omnicell, Inc. compare | 39.0× |
| WAY Waystar Holding Corp. compare | 40.9× |
| DOCS Doximity, Inc. compare | 44.4× |
| GDRX GoodRx Holdings, Inc. compare | 65.7× |
| PRVA Privia Health Group, Inc. | 88.3× |
| Health Information Services industry median | 42.0× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on PRVA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement